Literature DB >> 7567962

Insulin and epidermal growth factor receptors contain the cysteine repeat motif found in the tumor necrosis factor receptor.

C W Ward1, P A Hoyne, R H Flegg.   

Abstract

The insulin receptor (INSR) and epidermal growth factor receptor (EGFR) are representatives of two structurally related subfamilies of tyrosine kinase receptors. Using the Wisconsin GCG sequence analysis programs, we have demonstrated that the cysteine-rich regions of INSR and EGFR conform to the structural motif found in the tumor necrosis factor receptor (TNFR) family. The study also revealed that these regions were not composed of simple repeats of eight cysteine residues as previously proposed and that the second Cys-rich region of EGFR contained one fewer TNFR repeat than the first. The sequence alignments identified two cysteine residues in INSR that could be responsible for the additional disulfide bonds known to be involved in dimer formation. The published data on the alignments for the fibronectin type III repeat region of the INSR together with previous cysteine mutagenesis studies indicated that there were two disulfide bonds linking the alpha and beta chains of the INSR, but only one alpha-beta linkage in the insulin-like growth factor 1 receptor (IG1R). Database searches and sequence alignments showed that the TNFR motif is also found in the cysteine-rich repeats of laminins and the noncatalytic domains of furin-like proteases. If the starting position of the repeat is altered the characteristic laminin repeat of eight cysteine residues can be shown to consist of a TNFR-like motif fused to the last half of an EGF-like repeat. The overlapping regions of these two motifs are known to have identical disulfide bonding patterns and similar protein folds.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7567962     DOI: 10.1002/prot.340220207

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  24 in total

1.  Mutational analysis of the N-linked glycosylation sites of the human insulin receptor.

Authors:  T C Elleman; M J Frenkel; P A Hoyne; N M McKern; L Cosgrove; D R Hewish; K M Jachno; J D Bentley; S E Sankovich; C W Ward
Journal:  Biochem J       Date:  2000-05-01       Impact factor: 3.857

2.  Cloning and identification of a cDNA that encodes a novel human protein with thrombospondin type I repeat domain, hPWTSR.

Authors:  Jin-Zhong Chen; Shu Wang; Rong Tang; Quan-Sheng Yang; Enpeng Zhao; Yaoqiong Chao; Kang Ying; Yi Xie; Yu-Min Mao
Journal:  Mol Biol Rep       Date:  2002-09       Impact factor: 2.316

3.  Polymorphism of the epidermal growth factor receptor extracellular ligand binding domain: the dimer interface depends on domain stabilization.

Authors:  Zhiyong Zhang; Willy Wriggers
Journal:  Biochemistry       Date:  2011-02-18       Impact factor: 3.162

4.  The cysteine-rich domain of the secreted proprotein convertases PC5A and PACE4 functions as a cell surface anchor and interacts with tissue inhibitors of metalloproteinases.

Authors:  Nadia Nour; Gaétan Mayer; John S Mort; Alexandre Salvas; Majambu Mbikay; Charlotte J Morrison; Christopher M Overall; Nabil G Seidah
Journal:  Mol Biol Cell       Date:  2005-08-31       Impact factor: 4.138

5.  The role of distinct p185neu extracellular subdomains for dimerization with the epidermal growth factor (EGF) receptor and EGF-mediated signaling.

Authors:  T Kumagai; J G Davis; T Horie; D M O'Rourke; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

6.  Muc4-ErbB2 complex formation and signaling in polarized CACO-2 epithelial cells indicate that Muc4 acts as an unorthodox ligand for ErbB2.

Authors:  Victoria P Ramsauer; Vanessa Pino; Amjad Farooq; Coralie A Carothers Carraway; Pedro J I Salas; Kermit L Carraway
Journal:  Mol Biol Cell       Date:  2006-04-19       Impact factor: 4.138

Review 7.  The three dimensional structure of the type I insulin-like growth factor receptor.

Authors:  C W Ward; T P Garrett; N M McKern; M Lou; L J Cosgrove; L G Sparrow; M J Frenkel; P A Hoyne; T C Elleman; T E Adams; G O Lovrecz; L J Lawrence; P A Tulloch
Journal:  Mol Pathol       Date:  2001-06

Review 8.  EGFR-targeted therapies in the post-genomic era.

Authors:  Mary Jue Xu; Daniel E Johnson; Jennifer R Grandis
Journal:  Cancer Metastasis Rev       Date:  2017-09       Impact factor: 9.264

9.  Role of extracellular subdomains of p185c-neu and the epidermal growth factor receptor in ligand-independent association and transactivation.

Authors:  Toru Kumagai; Makoto Katsumata; Akihiro Hasegawa; Keiji Furuuchi; Toshiki Funakoshi; Ichiro Kawase; Mark I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-16       Impact factor: 11.205

10.  A Novel Signaling Complex between TROY and EGFR Mediates Glioblastoma Cell Invasion.

Authors:  Zonghui Ding; Alison Roos; Jean Kloss; Harshil Dhruv; Sen Peng; Patrick Pirrotte; Jennifer M Eschbacher; Nhan L Tran; Joseph C Loftus
Journal:  Mol Cancer Res       Date:  2017-11-08       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.